Questioning the Ban: E-cigarette Regulation in Argentina

Aug.15.2023
Questioning the Ban: E-cigarette Regulation in Argentina
Argentine e-cigarette association questions government regulations, claiming e-cigarettes reduce tobacco risks by 95%, calling for independent regulation.

According to Argentine media outlet Eleconomista, on August 14th, the Argentine e-cigarette association has raised concerns about the government's regulation policies on e-cigarettes. While acknowledging that e-cigarettes are not completely harmless, the association argues that for those who are unable or unwilling to quit smoking, e-cigarettes can reduce the risks associated with traditional tobacco by 95%. As a result, they are calling for independent regulation that does not treat e-cigarettes on par with traditional tobacco.


Approximately one million Argentines are currently using e-cigarettes.


E-cigarettes and heated tobacco products are gaining popularity worldwide, not only among those seeking non-combustible and lower nicotine options, but also among people who enjoy inhaling nicotine-free flavored vapor.


In Argentina, the use of these products has not been legally sanctioned, and it is estimated that there are currently around one million people nationwide using e-cigarettes.


However, since 2011, the sales, importation, distribution, promotion, and advertising of e-cigarettes have been prohibited according to the regulations set by the National Administration of Food, Drugs, and Medical Technology (ANMAT). Additionally, the Ministry of Health has banned the use of heated tobacco products starting from March 2023.


Compared to traditional cigarette smoking, the nicotine and approximately 7000 toxic substances in cigarettes are highly addictive and can potentially cause respiratory diseases, cardiovascular ailments, and various types of cancer, including lung, throat, and laryngeal cancers.


According to statistics released by the Ministry of Health in Argentina, 22.2% of adults over the age of 18 are smokers. Approximately 45,000 people die each year due to smoking, accounting for 14% of the total number of deaths.


Cigarette smoking continues to raise concerns every year due to its detrimental impact on health. Recent statistics reveal notable consequences, including 19,000 cancer diagnoses, 33,000 cases of pneumonia, 11,000 strokes, 61,000 hospitalizations caused by cardiovascular diseases, and over 100,000 new cases of chronic obstructive pulmonary disease (COPD).


Call for independent regulation.


An e-cigarette, formally known as a Nicotine Electronic Aerosolization System (SEAN) or a Non-Nicotine Electronic Aerosolization System (SESN), is a battery-operated device that heats a solution composed of propylene glycol, glycerin, and potentially flavorings to 250 degrees Celsius, producing an aerosol for consumer inhalation.


Furthermore, the heating of specially crafted tobacco leaves and pods containing nicotine in heated tobacco products (HTPs), without combustion, has been deemed toxic and carcinogenic by the World Health Organization (WHO). Therefore, the WHO states that HTPs should be regulated as "other products within the tobacco category" due to a lack of sufficient data indicating that they are less harmful than traditional cigarettes.


The Ministry of Health in Argentina has implemented strict regulations on e-cigarettes and PTC due to concerns about their potential health risks and addictive behavior.


However, the Argentine e-cigarette association acknowledges that e-cigarettes are not entirely harmless but claims that they reduce the risks associated with traditional tobacco by 95% for individuals who cannot or do not want to quit smoking.


As a result, they are calling for independent regulation and not treating it on par with traditional tobacco.


Juan Facundo Teme, chairman of the association, believes that the use of e-cigarettes in Argentina has been stigmatized. He is urging the government to study regulatory measures in countries like the United Kingdom and questions why prohibition is the only option for Latin American countries.


References: When writing articles or reports, it is crucial to include references to support the information provided. References serve as sources of evidence and credibility for the claims made in the piece. They allow readers to verify the information themselves and ensure accuracy. Citing references also demonstrates the author's research and diligence in gathering information from reliable sources. This adds depth and authority to the piece, increasing its reliability and trustworthiness. In academic writing, referencing is considered a standard practice, as it gives credit to the original authors and acknowledges their contributions to the field. It also helps to avoid plagiarism by clearly attributing ideas and information to their rightful owners. Proper referencing involves providing complete and accurate information about the sources used, including the author's name, publication date, title, and relevant details. Different citation styles, such as MLA, APA, and Chicago, have specific rules and formats for referencing various types of sources, such as books, journals, websites, and interviews. Including references in a written piece not only strengthens its credibility but also encourages further exploration and research on the subject matter. It allows readers to delve deeper into the topic and engage with the material on a more scholarly level. In conclusion, references play a vital role in journalistic writing. They elevate the quality and reliability of the piece, ensure accuracy, and recognize the contributions of others. By including proper references, writers demonstrate their commitment to intellectual honesty and integrity.


Vaping in Argentina: Is its prohibition reasonable?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
German Bundestag Passes Tobacco Tax Hikes: Vape Liquid Duty to Reach €0.44/ml, Heated Tobacco Taxes to Rise and Cigarettes Seen Near €12 a Pack
German Bundestag Passes Tobacco Tax Hikes: Vape Liquid Duty to Reach €0.44/ml, Heated Tobacco Taxes to Rise and Cigarettes Seen Near €12 a Pack
Germany's Bundestag passed amendments to the Tobacco Tax Act on October 15, 2026, setting out annual excise tax increases from 2027 through 2030 for e-cigarette liquids, heated tobacco, cigarettes and other tobacco products. Under the Finance Committee's amended bill, duty on qualifying e-liquids will rise from €0.32/ml in 2026 to €0.44/ml in 2030, an increase of 37.5%. Heated tobacco will retain its tax calculation based on 80% of the corresponding cigarette excise duty. The average price of a 20-cigarette pack is projected to approach €12 by 2030, with some brands potentially reaching €14. The legislation is projected to generate approximately €11.8 billion in additional tax revenue over four years and remains subject to further legislative procedures.
Regulations
Oct.19
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13